Suchergebnisse - "Fast track"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Quelle: British Journal of Pharmacology. 182:1416-1445

    Schlagwörter: CSF-1, Colony-stimulating factor-1, NSCLC, Non-small-cell lung cancer, TR-β, Thyroid hormone receptor-β, PN, Prurigo nodularis, CR, Complete remission, PD-L1, Programmed death-ligand 1, CDC, Complement-dependent cytotoxicity, ATMP, Advanced Therapy Medicinal Products, CHMP, Committee for Human Medicinal Products, MAGE, Melanoma antigen gene, AAV, Adeno-associated virus Ab, Antibody ABR, Annualised bleeding rate Acc, Accelerated approval ADCC, Cell-mediated cytotoxicity AKT, Protein kinase B ALK, Anaplastic lymphoma kinase ALL, Acute lymphoblastic leukaemia AML, Acute myelogenous leukaemia Apo, Apolipoprotein ARIA, β-amyloid-related imaging abnormalities ASO, Antisense oligonucleotide ATMP, Advanced Therapy Medicinal Products ATP, Adenosine triphosphate Aβ, Amyloid β BCG, Bacillus Calmette-Guérin vaccine Br, Breakthrough BRAF, Serine/threonineprotein kinase B-raf CD, Cluster differentiation CDC, Complement-dependent cytotoxicity CFTR, Cystic fibrosis transmembrane conductance regulator CHMP, Committee for Human Medicinal Products CLDN, Claudin COVID, Coronavirus disease COPD, Chronic obstructive pulmonary disease CR, Complete remission CRF-1, Corticotropin releasing factor-1 CRF 1 , CRF receptor 1 CSF-1, Colony-stimulating factor-1 CTLA-4, Cytotoxic T-lymphocyte-associated protein 4 DLL, Delta-like ligand 3 DMD, Duchenne muscular dystrophy DOR, Duration of response EMA, European Medicines Agency ETA/B, Endothelin-1 type A/B receptor FDA, Food and Drug Administration FIC, First-in-class FLT, FMS-like tyrosine kinase FCS, Familial chylomicronemia syndrome HDI, Histone deacetylase inhibitor FT, Fast-track GVHD, Graft-versus-host disease Hb, Haemoglobin HER, erb-b2 receptor tyrosine kinase HPCs, Haematopoietic progenitor cells HSCs, Haematopoietic stem cells ICI, Immune checkpoint inhibitors IDH, Isocitrate dehydrogenase IL, Interleukin JAK, Janus kinase MAb, Monoclonal antibody MAGE, Melanoma antigen gene MASH, Metabolic dysfunction-associated steatohepatitis MEK, Mitogen-activated protein kinase kinase MHRA, Medicines and Healthcare Products Regulatory Agency NAI, Nogapendekin alfa inbakicept NPC, Niemann-Pick type C NSCLC, Non-small-cell lung cancer NRG1, Neuregulin 1 ORR, Overall response rate PBC, Primary biliary cholangitis PBMC, Peripheral blood mononuclear cells PD-1, Programmed cell death protein 1 PD-L1, Programmed death-ligand 1 PN, Prurigo nodularis PNH, Paroxysmal nocturnal haemoglobinuria PPAR, Peroxisome proliferator-activated receptors RBC, Red blood cell RSV, Respiratory syncytial virus SARS-CoV2, Severe acute respiratory syndrome coronavirus 2 SCLC, Small-cell lung cancer TCR, T-cell receptor TFPI, Tissue factor pathway inhibitor TG, Triglycerides TIL, Tumour-infiltrating leukocytes TR-β, Thyroid hormone receptor-β, CFTR, Cystic fibrosis transmembrane conductance regulator, BRAF, Serine/threonineprotein kinase B-raf, IL, Interleukin, NAI, Nogapendekin alfa inbakicept, IDH, Isocitrate dehydrogenase, Apo, Apolipoprotein, AML, Acute myelogenous leukaemia, Acc, Accelerated approval, CRF-1, Corticotropin releasing factor-1, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Br, Breakthrough, GVHD, Graft-versus-host disease, AKT, Protein kinase B, TG, Triglycerides, DMD, Duchenne muscular dystrophy, DLL, Delta-like ligand 3, BCG, Bacillus Calmette-Guérin vaccine, Aβ, Amyloid β, [SDV] Life Sciences [q-bio], FLT, FMS-like tyrosine kinase, CTLA-4, Cytotoxic T-lymphocyte-associated protein 4, RBC, Red blood cell, FT, Fast-track, ARIA, β-amyloid-related imaging abnormalities, RSV, Respiratory syncytial virus, ATP, Adenosine triphosphate, PBC, Primary biliary cholangitis, JAK, Janus kinase, Hb, Haemoglobin, ABR, Annualised bleeding rate, FCS, Familial chylomicronemia syndrome, ALL, Acute lymphoblastic leukaemia, DOR, Duration of response, PD-1, Programmed cell death protein 1, MAb, Monoclonal antibody, COPD, Chronic obstructive pulmonary disease, AAV, Adeno-associated virus, Ab, Antibody, TIL, Tumour-infiltrating leukocytes, ASO, Antisense oligonucleotide, ALK, Anaplastic lymphoma kinase, MEK, Mitogen-activated protein kinase kinase, PNH, Paroxysmal nocturnal haemoglobinuria, CLDN, Claudin, HPCs, Haematopoietic progenitor cells, PPAR, Peroxisome proliferator-activated receptors, NPC, Niemann-Pick type C, NRG1, Neuregulin 1, CD, Cluster differentiation, HDI, Histone deacetylase inhibitor, FIC, First-in-class, HSCs, Haematopoietic stem cells, CRF 1 , CRF receptor 1, TFPI, Tissue factor pathway inhibitor, SARS-CoV2, Severe acute respiratory syndrome coronavirus 2, PBMC, Peripheral blood mononuclear cells, HER, erb-b2 receptor tyrosine kinase, FDA, Food and Drug Administration, ADCC, Cell-mediated cytotoxicity, COVID, Coronavirus disease, MHRA, Medicines and Healthcare Products Regulatory Agency, ICI, Immune checkpoint inhibitors, TCR, T-cell receptor, EMA, European Medicines Agency, ETA/B, Endothelin-1 type A/B receptor, ORR, Overall response rate, MASH, Metabolic dysfunction-associated steatohepatitis, SCLC, Small-cell lung cancer

    Dateibeschreibung: application/pdf

  8. 8

    Weitere Verfasser: University/Department: Universitat Autònoma de Barcelona. Departament de Cirurgia

    Thesis Advisors: Moret Ruiz, Enrique, Cámara Rosell, María Luisa, Oller Sales, Benjamí

    Quelle: TDX (Tesis Doctorals en Xarxa)

    Dateibeschreibung: application/pdf

  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Quelle: Eur Heart J
    Ryan, M, Petrie, M C, Dodd, M, Kontopantelis, E, Tong, G, Marquis-Gravel, G, Docherty, K, Clayton, T, Lansky, A, Mamas, M, Rouleau, J, Velazquez, E & Perera, D 2025, ' Medical therapy and outcomes in REVIVED-BCIS2 and STICHES : an individual patient data analysis ', European Heart Journal, vol. 46, no. 22, pp. 2052-2062 . https://doi.org/10.1093/eurheartj/ehaf080
    Perera, D, Ryan, M, Petrie, M C, Dodd, M, Kontopantelis, E, Tong, G, Marquis-Gravel, G, Docherty, K F, Lansky, A J, Mamas, M A, Rouleau, J-L & Velazquez, E J 2025, 'Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis', European Heart Journal. https://doi.org/10.1093/eurheartj/ehaf080

    Dateibeschreibung: application/pdf

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20